Illinois Governor J.B. Pritzker has signed two separate medical cannabis expansion bills into law.
Members of NAACP Denver and Minorities for Medical Marijuana join forces to address the lack of diversity and need for social equity within the marijuana industry.
A federal court has ordered the Drug Enforcement Administration to respond to a lawsuit charging the agency with failing to move forward with a 2016 policy to expand the total number of federally licensed marijuana cultivators.
Federal officials have approved plans for the University of Mississippi to grow 2,000 kilograms (4,409 pounds) of cannabis to provide to investigators for clinical trial research.
The State Health Department Secretary publicly announced on Thursday that patients diagnosed with anxiety disorders and/or Tourette’s syndrome will be eligible to receive recommendations to legally access medical cannabis products. The new rules take effect on July 20.
Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs. “Our findings suggest that de facto medical use may be highly prevalent among adult use customers, and that access to an adult use cannabis market may influence individuals’ use of other medications,” authors concluded.
Democratic Gov. Phil Murphy signed legislation into law today significantly amending and expanding the state’s medical cannabis access program. The new law takes immediate effect.
Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019.
A single paragraph buried in Pennsylvania’s medical marijuana law will start bringing some transparency to consumer-level prices. It could also have a profound influence on medical cannabis products nationwide.
Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs.